
DMPHF
Healthcare · Drug Manufacturers - Specialty & Generic · $1.92B market cap
$38.84-8.85 (-18.6%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 31, 2022 | Time not confirmed | — | 0.27 | — |
| Apr 11, 2022 | After the close | — | 0.69 | — |
| Nov 15, 2021 | After the close | 0.98 | 1.15 | +17.3% |
| Sep 6, 2021 | After the close | — | 0.74 | — |
| May 17, 2021 | After the close | 0.59 | 0.67 | +13.6% |
| Nov 15, 2020 | After the close | 0.43 | 0.42 | -2.3% |
| Sep 8, 2020 | After the close | 0.38 | 0.22 | -42.1% |
| Nov 19, 2019 | After the close | 0.44 | 0.36 | -18.2% |
| Sep 11, 2019 | After the close | 0.44 | 0.38 | -13.6% |
| Apr 16, 2019 | After the close | 0.44 | 0.36 | -18.2% |
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC…